Analysis of non-HLA genomic risk factors in HLA-matched unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia
Background Allogeneic hematopoietic cell transplantation is the main curative therapy for patients with chronic myeloid leukemia who do not respond to tyrosine kinase inhibitors. It has been proposed that non-human leukocyte antigen gene polymorphisms influence outcome after hematopoietic cell trans...
Główni autorzy: | , , , , , , , , , , |
---|---|
Format: | Artykuł |
Język: | English |
Wydane: |
Ferrata Storti Foundation
2012-07-01
|
Seria: | Haematologica |
Dostęp online: | https://haematologica.org/article/view/6344 |